IN Vitro Technologies, Inc.

Baltimore, MD 21227

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $500K
First Award Date 08/01/91
Most Recent Award Date 05/01/01

Key Personnel

Last Name Name Awards Contact
Ruegg Charles E Ruegg 1
Gierthy John F Gierthy 3

4 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/01 - 04/30/03

DESCRIPTION: (adapted from application) Towards developing an efficient and relevant in vitro method to screen estrogenic chemicals, the PI has finished his objectives of the Phase I STTR and optimized the MCF-7 focus formation assay. In this Phase II application, the PI proposes to validate the MCF-7 focus assay ...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/00 - 04/30/01

DESCRIPTION: (adapted from application) Towards developing an efficient and relevant in vitro method to screen estrogenic chemicals, the PI has finished his objectives of the Phase I STTR and optimized the MCF-7 focus formation assay. In this Phase II application, the PI proposes to validate the MCF-7 focus assay ...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/98 - 06/30/99

DESCRIPTION (adapted from abstract) Health consequences resulting from exposure to xenoestrogens and antiestrogens are expected. Because of the potential human health effects, regulatory agencies are now considering the requirement for industrial chemical with potential environmental and human exposure to be ev...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/91 - 07/31/92

DESCRIPTION: (Adapted from Applicant's Abstract) The goals of this project are to develop and validate an in vitro testing battery which mechanistically predicts the nephrotoxic potential of chemical agents. This in vitro testing battery is designed to detect direct cytotoxicity, hemodynamic, and pH dependent solubility mechanisms of injury. D...